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ABSTRACT 
Objective: The present study was performed to evaluate the immunomodulatory, anticancer, and antioxidative properties of the fraction (CP_2) 
isolated from Cyclea peltata.  
Methods: Immunomodulation was evaluated in lymphocytes by lymphocyte proliferation assay and in THP-1 macrophage cell lines by MTT assay. 
The nitrite production by the macrophages was also measured by the nitrite assay using griess reagent. The anticancer activity of the fraction was 
determined by MTT assay. The antioxidant activity was evaluated by DPPH assay and total antioxidant assay by phosphomolybdenum method. It is 
expressed as number of gram equivalent of ascorbic acid. 
Results: The plant fraction showed the presence of flavonoids which induced lymphocyte proliferation rate of 4.29±0.007 at 100 μg/ml. It was not 
toxic to THP-1 macrophage cells and also could induce nitrite production at 1 mg/ml. It also exhibited good anticancer activity at 100 μg/ml after 
48h of incubation. The DPPH activity was found to be low since 100 μg/ml showed only an inhibition rate of 22±0.026. The total antioxidant activity 
at 1000 μg/ml of CP_2 was found to be equivalent to 79±0.03 μg/ml of ascorbic acid exhibiting moderate antioxidant activity.  
Conclusion: The fraction CP_2 containing flavonoid, isolated from Cyclea peltata has good immunomodulatory, antioxidant and anticancerous property.  
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A number of currently available drugs have been developed from 
medicinal plants making them a regular source of medicine. Plants 
act as a source of a wide variety of secondary metabolites with 
potent pharmacological activity [1]. Plant-based drugs are popular 
due to their limited side effects and low cost. Mostly available 
chemotherapeutic drugs in the market have immunosuppressive 
effects along with a variety of side effects [2]. Immunomodulators 
derived from plants are gaining attention as they can overcome the 
side effects exerted by synthetic drugs [3]. Herbal 
immunostimulators are effective as nutrient supplement providing 
resistance as well as acting as immune strengtheners in 
immunocompromised conditions [4]. Phytochemicals modulate the 
immune system in different ways by acting on the different 
mechanisms of immune system [5].  
Cancer is one of the leading causes of death worldwide. Reports 
from WHO states that death due to cancer are predicted to rise to 
13.1 million by 2030 [6]. Among cancers, stomach cancer causes 
about 800,000 deaths worldwide per year. Eating salty, spicy and 
pickled food, excessive alcohol consumption, and infection by 
Helicobacter pylori and smoking may be associated with stomach 
cancer [7]. Unfortunately in more than 90% of cases, the disease 
would have reached an advanced stage by the time it is diagnosed. 
Hence, there is an urgent need to characterize these cancers through 
identifying potential biomarkers and novel therapeutic targets [8]. 
Nature serves as a never-ending source of anticancer drugs and 
almost 60% of this are from plants, marine organisms and 
microorganisms [9]. The oxidative damage caused by free radicals to 
biomolecules has been implicated in diseases like cancer, diabetes, 
arthritis, and neurodegenerative disorders. Occasionally, the natural 
antioxidant mechanisms fail to overcome the damage caused by free 
radicals, making antioxidant supplements necessary [10].  
Cyclea peltata (Lam.) Hook. f. and Thomson (Family: Menispermaceae) 
has a wide distribution in India. The National Medicinal Plant Board of 
India has termed this plant as “medicinal plant species in high trade 
sourced from tropical forests.” It is a known blood purifier and IQ 
enhancer [11]. Cyclea peltata roots have been reported to have 
antioxidant, antihyperlipidemic, antilithiasis and hepatoprotective 
activity. The leaves of the plant have antioxidant and antidiuretic 
activity [12]. The crude extract of this plant has been proven to have 
antimicrobial activity [13]. Their roots have been reported to contain 
alkaloids like fangchinoline, tetrandrine, cycleapeltine, cycleacurine, 
cycleadrine and cycleanorine [14]. Our study aims to isolate new 
biomolecules with immunomodulatory, anticancer and antioxidant 
properties from the plant.  
MATERIALS AND METHODS 
Chemicals 
Cell-culture media was purchased from Invitrogen and all other 
reagents from Himedia. All chemicals and solvents used were of 
analytical grade. 
Collection and preparation of plant sample 
Cyclea peltata (Lam.) Hook. f. and Thomson (CP) was collected from 
different locations in Kannur District, Kerala and taxonomically 
identified from Dept. of Botany, Govt. Brennen College, Thalassery, 
Kannur. The plant was deposited in their herbarium with voucher 
number 3952. Only the leaves of the plant were taken for the study. 
It was washed with tap water, rinsed with distilled water and 
blotted gently between the folds of filter paper and shade dried. The 
dried plant material was powdered using mixer grinder and stored 
in an airtight container. 
Extraction and isolation 
Plant powder was subjected to successive soxhlet extraction using 
hexane, chloroform, and ethyl acetate and methanol-based on the 
increasing order of polarity for 24 h each. The ethyl acetate fraction, 
which exhibited the highest immunomodulatory property, was further 
subjected to successive column chromatography using silica gel of 60-
120 mesh size and followed by 200-400 mesh size respectively. Elution 
was carried out using solvents of increasing polarity starting from n-
hexane followed by ethyl acetate, methanol and water. The fractions 
International Journal of Pharmacy and Pharmaceutical Sciences 
Print ISSN: 2656-0097 | Online ISSN: 0975-1491                          Vol 11, Issue 10, 2019 
Variyar et al. 
Int J Pharm Pharm Sci, Vol 11, Issue 10, 40-46 
41 
were collected and pooled based on their immunomodulatory activity 
and TLC pattern. The fractions were then dried and stored. The 
percentage yield of the fractions was determined. 
Phytochemical screening 
The fraction was screened for the presence of phytochemicals 
including phenols, flavonoids, tannins, saponins, alkaloids, 
glycosides, terpenoids and phytosterols by using standard 
protocols [15].  
HPTLC analysis 
5 µl of the sample was applied on the TLC Silica gel 60 F254 
aluminium plate using Camag Linomat automatic sample applicator 
using microsyringe. The sample was loaded onto the plate and was 
separated in one dimension using mobile solvent ethyl acetate: 
methanol: water (5:1:5 v/v/v) at room temperature. After the 
development of the plate, it was air-dried and visualized using 
Camag TLC Visualizer. 
Analytical HPLC analysis 
For HPLC, Agilent 1200 High-Pressure Liquid Chromatographic 
system equipped with prep pump, a Rheodyne injector, Diode Array 
Detector in combination with Chem32 was used. The injection 
volume of sample was 20 µl with a flow rate of 1.0 ml/min using the 
methanol: water solvent system in the ratio 20:80. The running time 
was for 10 min. 
In vitro lymphocyte proliferation assay 
The immunomodulatory activity was checked on isolated human 
lymphocytes from blood [16]. Fresh human blood samples 
collected were layered on equal volumes of Hi-Sep LSM solution 
and centrifuged at 800 x g for 25 min at 18˚C. The thin white 
middle lymphocyte layer was collected and washed with RPMI-
1640 media twice and centrifuged at 100 x g for 10 min at 18˚C. 
After discarding the supernatant, the cells were suspended in 10% 
RPMI-1640. The cell number was counted with a hemocytometer. 
Cells were seeded at a concentration of 20,000 cells/well in a 96-
well plate and 100 μl of each extract at various concentrations (1-
1000 μg/ml) was added to the wells. The plates were then 
incubated for 72 h in a CO2 incubator. After incubation, 20μl MTT 
(5000μg/ml) was added to each well and incubation was 
continued for an additional 4 h. The insoluble formazan crystals 
formed were solubilized by the addition of 100μl MTT lysis buffer 
(SDS, dimethylformamide and distilled water) followed by an 
incubation of 2 h and the absorbance measured at 570 nm using a 
Biorad iMark microplate reader. The proliferation rate (PR) was 
calculated. 
Proliferation Rate =< Absorbance of test ÷ Absorbance of control >× 100 
Proliferation Index = Proliferation Rate ÷ 100 
Macrophage assays 
THP-1 cells were obtained as a gift from Centre for DNA 
Fingerprinting and Diagnostics, Hyderabad. It was cultured in RPMI 
1640 medium supplemented with 10% FBS, Penicillin (100U/ml), 
Streptomycin (100µg/ml) and Amphotericin B (250µg/ml) in a 
humidified atmosphere at 37°C with 5% CO2. The cell viability was 
determined using Trypan blue. The cells were differentiated into 
macrophages using 0.1 μg/ml PMA. 4 x 104cells were seeded in 96 
well plates containing complete medium with PMA. After 72 h, the 
medium was removed and washed with prewarmed PBS. 1-1000 
µg/ml of CP_2 extract was added to the plates. MTT assay was 
performed 24 and 48 h after the addition of extract, as mentioned in 
the protocol above.  
Nitrite assay 
The nitrite present in the supernatant of the treated cells was 
assayed by the Griess reaction. An equal volume of supernatant and 
Griess reagent was mixed. It was covered and subjected to shaking 
for 10 min. The absorbance was measured at 550 nm on Bio-Rad 
iMark microplate reader. 1 to 10µg/ml sodium nitrite was used as 
the standard [17]. 
Anticancer activity by MTT assay 
The ant cancerous assay was carried out using HCT-116 human 
colon carcinoma cells maintained as monolayer cultures in RPMI 
medium supplemented with 10% Fetal Calf Serum, Penicillin G (100 
U/ml), Streptomycin (100 μg/ml) and Gentamycin (50 μg/ml). 
Briefly, 1×104 cells ml-1 was seeded in each well of a96 well plate 
and incubated overnight at 37 °C in a humidified 5% CO2/95% air 
atmosphere. When the cells in the 96 well plates were 80% 
confluent, the medium was removed from each well and the extracts 
at different concentrations (1-1000 μg/ml) were added. The plates 
were then kept for 24, 48 and 72 h of incubation. After incubation, 
the culture medium was discarded followed by the addition of 100μl 
of MTT solution. MTT treatment of live cells produced a dark blue 
formazan product, which was solubilized by the addition of 100μl of 
SDS lysis buffer after 4 h of incubation. Absorbance was measured 
after 2 h of incubation at 570 nm [18]. The Inhibitory Rate (Ir) was 
calculated from the equation:  
Inhibition Rate = 100– Proliferation Rate 
DPPH radical scavenging assay 
DPPH (1, 1-Diphenyl-2-picrylhydrazyl) is a stable free radical used 
for quantification of natural antioxidants [19]. Due to the presence 
of a free-electron it gives a strong absorbance at 517 nm. On 
accepting hydrogen from a corresponding donor, the solution loses 
the characteristic deep purple colour and the discoloration was 
proportional to the concentration and scavenging activity of the 
compound. The reaction mixture contained 2.8 ml of 100µM DPPH 
dissolved in methanol and various concentrations (1-1000μg/ml) of 
compounds. This mixture was incubated at room temperature for 30 
min. After shaking, absorbance was measured at 517 nm. The 
percentage of DPPH scavenging activity was calculated. Ascorbic 
acid served as positive control. 
Total antioxidant assay (TAA) 
The total antioxidant assay is based on the reduction of molybdenum 
(VI) to molybdenum (V) to form a green phosphate complex [20]. Briefly, 
0.3 ml of different extracts ranging from 1-1000 μg/ml concentration 
was mixed with 3 ml of reagent solution (0.6 M sulfuric acid, 28 mM 
sodium phosphate and 4 mM ammonium molybdate). Reaction mixture 
was incubated at 95 ̊ C for 90 min underwater bath. Absorbance at 695 
nm was measured after cooling to room temperature. Ascorbic acid was 
used as the standard. 
TAA is expressed as the number of equivalents of ascorbic acid. 
Statistical analysis 
Data were expressed as means±standard deviations (SD) of the 
triplicate values. The significance of the data was analyzed by 
one-way analysis of variance (ANOVA) using SPSS Statistics 20 
software. The P value<0.05 was considered statistically 
significant. 
RESULTS 
The ethyl acetate extract (crude) of Cyclea peltata recorded the highest 
immunomodulatory potential and was selected for column 
chromatography. The active fraction obtained from 60-120 mesh size 
silica using ethyl acetate: methanol (2:1 to 1:5) was further subjected 
to column chromatography using silica gel of 200-400 mesh size. A 
yellow active water-soluble fraction CP_2 (Ethyl acetate: Methanol–
1:4) was obtained. The percentage yield of the fraction was 0.48%.  
Phytochemical screening 
Phytochemical screening of CP_2 confirmed the presence of 
flavonoids. Results for all the other phytochemicals including 
alkaloids, terpenoids, steroids, polysaccharides, proteins, tannins, 
saponins, and glycosides were negative.  
HPTLC analysis 
Following HPTLC analysis, the fraction was visualized at 254 nm. 
Two compounds were visible with Rf values of 0.67 and 0.40 (fig. 1) 
thus confirming the presence of two compounds in the fraction. 
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HPLC analysis 
After HPLC analysis, the fraction indicated the presence of two 
peaks. Peak 1 was obtained at retention time 1.662 with a peak area 
of 38.331% and peak 2 was obtained at retention time 3.010 with a 
peak area of 61.668% (fig. 2). The HPLC analysis further confirms 
the presence of two compounds in the fraction. 
 
 
Fig. 1: HPTLC profile of CP_2 at 254 nm 
 
In vitro lymphocyte proliferation assay 
Different concentrations of CP_2 ranging from 1μg/ml-1000µg/ml 
were used for performing the in vitro lymphocyte proliferation 
assay. A concentration-dependent increase in proliferation was seen. 
PHA (1-10μg/ml) was used as positive standard. The proliferation 
index of 100 µg/ml of fraction is 4.29±0.007. 1000 µg/ml of CP_2 
induced four times more proliferation when compared to 100 µg/ml 
of the fraction (fig. 3). No toxicity to the cells was observed. 1 µg/ml 
of CP_2 was found equivalent to 1 µg/ml of PHA. So the fraction has 
shown to have very good proliferative capacity which can be made 
use in the case of immunosuppressed patients. 
Macrophage viability assay  
The viability of macrophages upon treatment with CP_2 was checked 
using MTT assay. The fraction was nontoxic to macrophages even up 
to a concentration of 1000μg/ml. This proves that the fraction did 
not inhibit normal cells and can be effectively developed into a 
potent drug upon purification. 
Nitrite assay 
The concentration of the stable nitrite in the supernatant of the 
macrophages was assessed using Griess reaction. Sodium nitrate 
(0.1-0.75 µg/ml) was used as a positive standard. The amount of 
nitrite generated was quantified from the calibration curve of 
sodium nitrate.24 h after addition, 1 µg/ml concentration of the 
sample did not induce nitrite production. 1000 µg/ml of CP_2 
induced 0.617±0.01 µg/ml of nitrite concentration after 48h 
incubation (fig. 4). This indicates the role of CP_2 in activating 




Fig. 2: HPLC profile of CP_2 
 
 
Fig. 3: Lymphocyte proliferation assay of CP_2 (n = 3; Data expressed as mean±SD; p<0.05) 
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Fig. 4: Nitrite assay of macrophages at various concentrations (n = 3, data expressed as mean±SD; p<0.05) 
 
 
Fig. 5: Nitrite assay of standard (n = 3; data expressed as mean±SD) 
 
Anticancer activity by MTT assay 
The anticancer activity of Cyclea peltata was evaluated in human colon 
carcinoma cell line HCT-116 for 24, 48 and 72 h of incubation. There 
was an increasing inhibition rate with increasing concentration and 
time. At 1 μg/ml of fraction, no inhibition was seen at 24 and 48 h of 
incubation. Maximum inhibition of 75±0.0025 % was obtained after 
72 h of incubation. The IC50 value was obtained at 800 μg/ml, 100 
μg/ml and 50 μg/ml after 24, 48 and 72 h of incubation making the 
fraction a possible drug candidate against stomach cancers (fig. 6). 
 
 
Fig. 6: Anticancer activity of CP_2 at different concentrations (n = 3, data expressed as mean±SD; p<0.05) 
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DPPH radical scavenging assay 
DPPH assay evaluated the free radical scavenging capacity of CP_2. 
Ascorbic acid was used as standard. A range of 1-1000 µg/ml of the 
sample was used for the assay. The DPPH scavenging potential of the 
fraction was low. Even 1000 µg/ml of the fraction couldn’t attain an 
IC50 value. The 1 mg/ml of the fraction was found to be equivalent to 
0.064±0.007 mg/ml of ascorbic acid (fig. 7 and 8). 
 
 
Fig. 7: DPPH scavenging activity of CP_2 at different concentrations (n = 3, data expressed as mean±SD; p<0.05) 
 
 
Fig. 8: DPPH scavenging activity of ascorbic acid at different concentration (n = 3, data expressed as mean±SD) 
  
 
Fig. 9: Total antioxidant capacity of CP_2 at various concentration (n = 3, data expressed as mean±SD p<0.05) 
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Fig. 10: Total antioxidant activity of ascorbic acid at various concentrations (n = 3, data expressed as mean±SD) 
 
Total antioxidant assay 
The phosphomolybdenum method is based on the reduction of 
molybdenum (VI) to molybdenum (V) by CP_2 extract. A concentration 
range of 1-1000 µg/ml of the fraction was used for the assay. Ascorbic 
acid was used as standard. 1 mg/ml concentration of CP_2 fraction 
was equivalent to 79±0.03 µg/ml of ascorbic acid (fig. 9 and 10). 
Even though the CP_2 fraction did not show significant DPPH 
scavenging activity, it’s capacity to reduce Mo (VI) to Mo (V) 
indicates the ability to scavenge free radicals, increased levels of 
which are the cause of various diseases. Hence, this fraction can be 
further purified, identified and developed into an active drug 
molecule for immunity-related diseases. 
DISCUSSION 
Secondary metabolites play an essential role in human health and 
drug discovery based on plant metabolites is increasing day by day 
[21]. A large number of medicinal plants have already been 
exploited for the pursuit of drug discovery. But still a large number 
of plants which are used in Ayurveda need scientific validation [22]. 
An attempt to evaluate the immunomodulatory, anticancer and 
antioxidant property of Cyclea peltata has been taken up in this 
study. We could isolate a fraction CP_2 with potent 
immunomodulatory, anticancer and antioxidant properties. It is a 
water-soluble flavonoid. Presence of flavonoids in the crude extract 
has been previously reported but only alkaloids have been isolated 
from Cyclea peltata till date [23]. Our immune system strictly 
controls and prevents various infections and diseases from affecting 
our body. Among the cells of the immune system, the monocytes 
play an unavoidable role in the innate immune response by 
migrating to infection sites and differentiating into macrophages and 
activating various cytokines initiating adaptive immune response 
[24]. CP_2 was also capable of proliferating lymphocytes, which are 
the major cells involved in adaptive immunity, effectively at100 
µg/ml. Even at 1000 µg/ml, the fraction didn’t show any toxicity; 
instead it stimulated lymphocytes to proliferate four times than 
compared to100 µg/ml. This proves that the fraction is capable of 
activating cell-mediated immunity [25]. NO plays a crucial role in the 
host defence mechanism. Low doses of NO have been proven to 
protect cells from apoptosis and also can induce the expression of 
cytokines like IL-1, IL-6, IL-8 Tumor Necrosis Factor (TNF) and IL-
12 [26]. So CP_2 can help in regulating the immune mechanism by 
stimulating macrophages. Further purification of the compound can 
help in the identification and development of a lead drug molecule 
for the use by immune-compromised individuals.  
Intervention of natural phenolic compounds has been reported at all 
the stages of cancer. They exert their effect by acting on DNA repair 
mechanisms, inhibition of cell cycle, downregulation of MMP’s, 
induction of apoptosis and cell cycle arrest [27]. Phytocompounds 
like vinblastine, vincristine, topotecan and irinotechan are few 
examples of clinically used anticancer drugs [28, 29]. Its effect on 
HCT-116 colon cancer cell line proves it to be a good anticancer 
drug. 50 µg/ml of CP_2 with 72 h of incubation, showed an 
inhibition rate of 75%. So the combined action of two 
compounds in the fraction has a profound influence on their 
anticancer activity. Their purified form may be having more 
effective outcome on the cancer cell line even at low 
concentration and time. Antioxidants based drug formulations 
are used for the treatment of diseases like cancer, 
atherosclerosis, diabetes and stroke [30, 31]. CP_2 have 
exhibited total antioxidant activity, but DPPH activity was 
comparatively low. So they are capable of scavenging free 
radicals and thereby protecting from diseases. The further 
purification and characterization of the fraction into single 
compound will help in developing a drug with potent anticancer 
and immunomodulatory drug. 
CONCLUSION 
The current study evaluates the immunomodulatory, anticancer and 
antioxidant activity of a single fraction of Cyclea peltata. A yellow 
active fraction was isolated using Ethyl acetate: methanol (1:4). The 
fraction gave a good yield and is water-soluble. The HPTLC and 
HPLC analysis of the sample indicates the presence of two 
compounds in the fraction. Phytochemical analysis showed the 
presence of flavonoids. The fraction exhibits immunomodulatory 
potential since it stimulates the proliferation of lymphocytes and 
macrophages. The nitrite generation in macrophages is also 
indication of activation of macrophages. Even though the CP_2 
fraction did not show significant DPPH scavenging activity, the 
capacity to reduce Mo (VI) to Mo (V) indicates the ability to scavenge 
free radicals which are the cause of various diseases. Hence, this 
fraction can be further purified, identified and developed into an 
active drug molecule for immunity-related diseases. 
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